HR Baumgartner

2.7k total citations
53 papers, 2.3k citations indexed

About

HR Baumgartner is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, HR Baumgartner has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hematology, 15 papers in Cardiology and Cardiovascular Medicine and 13 papers in Surgery. Recurrent topics in HR Baumgartner's work include Platelet Disorders and Treatments (27 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). HR Baumgartner is often cited by papers focused on Platelet Disorders and Treatments (27 papers), Blood Coagulation and Thrombosis Mechanisms (18 papers) and Antiplatelet Therapy and Cardiovascular Diseases (14 papers). HR Baumgartner collaborates with scholars based in Switzerland, United States and France. HR Baumgartner's co-authors include VT Turitto, Vincent T. Turitto, HJ Weiss, T. Tschopp, H J Weiss, Paul Hadváry, Daniel Kirchhofer, Dominique Meyer, Yale Nemerson and KS Sakariassen and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Physiology.

In The Last Decade

HR Baumgartner

53 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HR Baumgartner Switzerland 25 1.6k 605 502 424 308 53 2.3k
HJ Weiss United States 24 1.3k 0.8× 485 0.8× 414 0.8× 284 0.7× 162 0.5× 45 2.0k
LA Harker United States 19 979 0.6× 389 0.6× 514 1.0× 368 0.9× 283 0.9× 28 1.8k
J J Sixma Netherlands 20 952 0.6× 368 0.6× 421 0.8× 334 0.8× 229 0.7× 44 1.7k
H J Weiss United States 15 1.0k 0.6× 454 0.8× 352 0.7× 243 0.6× 155 0.5× 18 1.7k
Sacha M. Dopheide Australia 16 1.3k 0.8× 437 0.7× 456 0.9× 375 0.9× 134 0.4× 17 1.7k
Imke C.A. Munnix Netherlands 20 1.1k 0.7× 306 0.5× 491 1.0× 207 0.5× 195 0.6× 23 1.8k
Stéphane Loyau France 27 875 0.5× 630 1.0× 554 1.1× 505 1.2× 438 1.4× 67 2.5k
P G de Groot Netherlands 22 794 0.5× 190 0.3× 256 0.5× 282 0.7× 109 0.4× 34 1.8k
Mercè Roqué Spain 26 705 0.4× 386 0.6× 880 1.8× 831 2.0× 277 0.9× 72 2.9k
Burt Adelman United States 25 695 0.4× 249 0.4× 1.1k 2.2× 1.1k 2.6× 809 2.6× 56 2.3k

Countries citing papers authored by HR Baumgartner

Since Specialization
Citations

This map shows the geographic impact of HR Baumgartner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HR Baumgartner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HR Baumgartner more than expected).

Fields of papers citing papers by HR Baumgartner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HR Baumgartner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HR Baumgartner. The network helps show where HR Baumgartner may publish in the future.

Co-authorship network of co-authors of HR Baumgartner

This figure shows the co-authorship network connecting the top 25 collaborators of HR Baumgartner. A scholar is included among the top collaborators of HR Baumgartner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HR Baumgartner. HR Baumgartner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roux, Sébastiên, T. Tschopp, & HR Baumgartner. (1996). Effects of napsagatran (Ro 46-6240), a new synthetic thrombin inhibitor and of heparin in a canine model of coronary artery thrombosis: comparison with an ex vivo annular perfusion chamber model.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 71–78. 15 indexed citations
2.
Kirchhofer, Daniel, T. Tschopp, Beat Steiner, & HR Baumgartner. (1995). Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood. 86(10). 3815–3822. 48 indexed citations
3.
Kirchhofer, Daniel, T. Tschopp, Paul Hadváry, & HR Baumgartner. (1994). Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.. Journal of Clinical Investigation. 93(5). 2073–2083. 120 indexed citations
4.
Kirchhofer, Daniel, KS Sakariassen, Martine Clozel, et al.. (1993). Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood. 81(8). 2050–2058. 64 indexed citations
5.
Kirchhofer, Daniel, Paul Hadváry, Thomas Weller, et al.. (1992). Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor. Blood. 80(10). 2539–2547. 1 indexed citations
6.
Clozel, Martine, Herbert Kühn, & HR Baumgartner. (1989). Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood. Blood. 73(3). 729–733. 16 indexed citations
7.
Baumgartner, HR & Markus Hosang. (1988). Platelets, platelet-derived growth factor and arteriosclerosis. Cellular and Molecular Life Sciences. 44(2). 109–112. 16 indexed citations
8.
Sadler, J. Evan, et al.. (1987). SYNTHETIC RGD-CONTAINING PEPTIDES OF VON WILLEBRAND FACTOR INHIBIT PLATELET ADHESION TO COLLAGEN. Thrombosis and Haemostasis. 64(4). 589–93. 19 indexed citations
9.
Weiss, HJ, VT Turitto, & HR Baumgartner. (1986). Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood. 67(2). 322–330. 150 indexed citations
10.
11.
12.
Dk, Meyer, J. M. Lavergne, HR Baumgartner, et al.. (1983). Mono clonal antibodies to human von willebrand factor role of intra molecular loci in mediation of platelet adhesion to the subendothelium. Thrombosis and Haemostasis. 50(1). 191. 1 indexed citations
13.
Baumgartner, HR, et al.. (1981). Aggregating Activity Of Structural Analogues Of Platelet Activating Factor (PAF): High Stereospecificity. Thrombosis and Haemostasis. 1 indexed citations
14.
15.
Weiss, HJ, et al.. (1978). Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand disease. Blood. 51(2). 267–279. 5 indexed citations
16.
Weiss, H J, Vincent T. Turitto, & HR Baumgartner. (1978). Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate--dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome.. PubMed. 92(5). 750–64. 309 indexed citations
17.
Baumgartner, HR. (1977). [The pathogenesis of atherosclerosis. Contribution from a cytobiological viewpoint].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 107(21). 717–22. 3 indexed citations
18.
Baumgartner, HR, et al.. (1977). Shear Rate Dependence of Platelet Adhesion to Collagenous Surfaces in Willebrand Factor-Depleted Blood. Thrombosis and Haemostasis. 8 indexed citations
19.
Baumgartner, HR. (1977). Platelet and Fibrin Deposition on Subendothelium: Opposite Dependence on Blood Shear Rate. Thrombosis and Haemostasis. 2 indexed citations
20.
Baumgartner, HR & G. V. R. Born. (1968). 5-Hydroxytryptamine in rabbit platelets and their aggregation.. PubMed. 194(2). 92–3P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by HJ Weiss Breakdown of academic impact, for papers by LA Harker Breakdown of academic impact, for papers by J J Sixma Breakdown of academic impact, for papers by H J Weiss Breakdown of academic impact, for papers by Sacha M. Dopheide Breakdown of academic impact, for papers by Imke C.A. Munnix Breakdown of academic impact, for papers by Stéphane Loyau Breakdown of academic impact, for papers by P G de Groot Breakdown of academic impact, for papers by Mercè Roqué Breakdown of academic impact, for papers by Burt Adelman
Rankless by CCL
2026